Lina U. Ivert
YOU?
Author Swipe
View article: The risk of venous thromboembolism in atopic dermatitis: a population-based cohort study
The risk of venous thromboembolism in atopic dermatitis: a population-based cohort study Open
Background Atopic dermatitis (AD) is a common inflammatory skin disease. Evidence on baseline venous thromboembolism (VTE) risk is inconsistent, but a clear understanding of this risk may be crucial in disease management. Objectives To eva…
View article: Increased mortality due to lymphoma and infections in patients with mycosis fungoides or Sézary syndrome: a Swedish nationwide population-based cohort study
Increased mortality due to lymphoma and infections in patients with mycosis fungoides or Sézary syndrome: a Swedish nationwide population-based cohort study Open
This large population-based study confirms lymphoma as the leading cause of death in patients with mycosis fungoides/Sézary syndrome (MF/SS), particularly those with severe disease. Patients with MF/SS also had higher mortality from infect…
View article: Identification of subgroups of early-stage mycosis fungoides patients with increased itch and impaired quality of life
Identification of subgroups of early-stage mycosis fungoides patients with increased itch and impaired quality of life Open
Introduction Mycosis fungoides (MF), Sézary syndrome (SS) and other cutaneous T-cell lymphomas (CTCLs) can have a severe impact on quality of life (QoL) and itch, but early MF is insufficiently investigated despite representing most patien…
View article: When Are Single Reader Evaluations Insufficient in Teledermoscopic Assessments? Analyses of a Retrospective Cohort Study
When Are Single Reader Evaluations Insufficient in Teledermoscopic Assessments? Analyses of a Retrospective Cohort Study Open
Background: Teledermoscopy (TDS) emerges as an efficient tool for diagnosing skin lesions. In Sweden, double reading is the standard of care, but risk factors for misdiagnosis or mismanagement using single reader evaluations (SRE) are not …
View article: Corrigendum: Exploring the educational needs of patients with cutaneous lymphoma using an educational needs assessment tool
Corrigendum: Exploring the educational needs of patients with cutaneous lymphoma using an educational needs assessment tool Open
[This corrects the article DOI: 10.3389/fonc.2024.1433821.].
View article: Risk Factors Associated with Weight Gain during Treatment with Dupilumab among Patients with Moderate to Severe Atopic Dermatitis
Risk Factors Associated with Weight Gain during Treatment with Dupilumab among Patients with Moderate to Severe Atopic Dermatitis Open
This cohort study used prospectively collected data from the Swedish national quality registry, SwedAD, to investigate weight gain as a possible side effect of dupilumab treatment for atopic dermatitis. Patients on dupilumab were compared …
View article: Exploring the educational needs of patients with cutaneous lymphoma using an educational needs assessment tool
Exploring the educational needs of patients with cutaneous lymphoma using an educational needs assessment tool Open
Background Cutaneous T-cell lymphomas (CTCL) are a group of rare non-Hodgkin lymphomas characterized by initial localization of malignant T-lymphocytes in the skin. Support and information from nurses and patient support groups have proven…
View article: Analysis of the Stockholm Public Health Cohort: Exploring How Ultraviolet Radiation and Other Factors Associate with Skin Cancer
Analysis of the Stockholm Public Health Cohort: Exploring How Ultraviolet Radiation and Other Factors Associate with Skin Cancer Open
Objective . The primary aims of the study were to (1) explore the association of skin cancer and four ultraviolet radiation (UVR) indicators (sunbed use, healthcare data on diagnosed melanocytic nevi (MN) and actinic keratosis (AK), and la…
View article: Establishment and Utility of SwedAD: A Nationwide Swedish Registry for Patients with Atopic Dermatitis Receiving Systemic Pharmacotherapy
Establishment and Utility of SwedAD: A Nationwide Swedish Registry for Patients with Atopic Dermatitis Receiving Systemic Pharmacotherapy Open
SwedAD, a Swedish nationwide registry for patients with atopic dermatitis receiving systemic pharmacotherapy, was launched on 1 September 2019. We describe here the establishment of a user-friendly registry to the benefit of patients with …
View article: Lead Time From First Suspicion Of Malignant Melanoma In Primary Care To Diagnostic Excision: A Cohort Study Comparing Teledermatoscopy And Traditional Referral To A Dermatology Clinic At A Tertiary Hospital
Lead Time From First Suspicion Of Malignant Melanoma In Primary Care To Diagnostic Excision: A Cohort Study Comparing Teledermatoscopy And Traditional Referral To A Dermatology Clinic At A Tertiary Hospital Open
Introduction The increasing use of teledermatoscopy in clinical practice has led to demands to evaluate the effects of this new technology on traditional healthcare systems. Objectives To study lead times from first consultation in primary…
View article: The Impact of Systemic Treatment of Atopic Dermatitis on Depressive Symptoms: A Prospective Clinical Cohort Study
The Impact of Systemic Treatment of Atopic Dermatitis on Depressive Symptoms: A Prospective Clinical Cohort Study Open
Information on depressive symptoms among patients with atopic dermatitis (AD) undergoing systemic treatment in a real-world setting is scarce. This prospective real-world clinical cohort study analysed data from SwedAD, a Swedish national …
View article: Atopic dermatitis in adults : epidemiological studies of comorbidity and studies of patients on systemic treatment
Atopic dermatitis in adults : epidemiological studies of comorbidity and studies of patients on systemic treatment Open
Background: Atopic dermatitis (AD) is one of the most common chronic skin disorders globally. It is an itchy inflammatory skin disease that can have a detrimental impact on health-related quality of life. In recent years, AD has been assoc…
View article: Association between atopic dermatitis and autoimmune diseases: a population‐based case–control study*
Association between atopic dermatitis and autoimmune diseases: a population‐based case–control study* Open
This large population-based study indicates significant autoimmune comorbidity of adults with AD, especially between AD and autoimmune dermatological, gastrointestinal and rheumatological diseases. Having multiple autoimmune diseases resul…
View article: Weight gain in patients with severe atopic dermatitis treated with dupilumab: a cohort study
Weight gain in patients with severe atopic dermatitis treated with dupilumab: a cohort study Open
Background Dupilumab, targeting the interleukin-4α receptor and inhibiting the action of interleukin-4 and interleukin-13, was recently approved for treatment of moderate to severe atopic dermatitis. There is limited data on long-term effe…
View article: Weight gain in patients with severe atopic dermatitis treated with dupilumab: a cohort study
Weight gain in patients with severe atopic dermatitis treated with dupilumab: a cohort study Open
Background Dupilumab, targeting the interleukin-4α receptor and inhibiting the action of interleukin-4 and interleukin-13, was recently approved for treatment of moderate to severe atopic dermatitis. There is limited data on long-term effe…
View article: Weight gain in patients with severe atopic dermatitis treated with dupilumab: a cohort study
Weight gain in patients with severe atopic dermatitis treated with dupilumab: a cohort study Open
Background Dupilumab, targeting the interleukin-4α receptor and inhibiting the action of interleukin-4 and interleukin-13, was recently approved for treatment of moderate to severe atopic dermatitis. There is limited data on long-term effe…
View article: Weight gain in patients with severe atopic dermatitis treated with dupilumab: a case series
Weight gain in patients with severe atopic dermatitis treated with dupilumab: a case series Open
Background Dupilumab, targeting the interleukin-4α receptor and inhibiting the action of interleukin-4 and interleukin-13, was recently approved for treatment of moderate to severe atopic dermatitis. There is limited data on long-term effe…
View article: Management of Ocular Manifestations of Atopic Dermatitis: A Consensus Meeting Using a Modified Delphi Process
Management of Ocular Manifestations of Atopic Dermatitis: A Consensus Meeting Using a Modified Delphi Process Open
There is a need for unified guidance on the management of ocular manifestations of atopic dermatitis and ocular manifestations associated with dupilumab in the Nordic region (Denmark, Finland, Norway and Sweden). This initiative gathered N…
View article: Erratum2: Association Between Atopic Dermatitis and Cardiovascular Disease: A Nationwide Register-based Case-control Study from Sweden
Erratum2: Association Between Atopic Dermatitis and Cardiovascular Disease: A Nationwide Register-based Case-control Study from Sweden Open
is missing (Erratum)
View article: Eye Complications During Dupilumab Treatment for Severe Atopic Dermatitis
Eye Complications During Dupilumab Treatment for Severe Atopic Dermatitis Open
Dupilumab, the first biologic approved for treatment of atopic dermatitis, has demonstrated significant clinical effect and quality of life-enhancing capacity in clinical trials. In these, dupilumab-associated conjunctivitis where reported…
View article: Association Between Atopic Dermatitis and Cardiovascular Disease: A Nationwide Register-based Case-control Study from Sweden
Association Between Atopic Dermatitis and Cardiovascular Disease: A Nationwide Register-based Case-control Study from Sweden Open
The associations between atopic dermatitis (AD) and cardiovascular disease (CVD) are debated. The aim of this study was to investigate the association between AD and coronary artery disease or ischaemic stroke in a nationwide, register-bas…